Dynamically self-adjusting magnetometer

Patent Registration – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Broadband Discovery Systems, Inc. patent solves the following problem:

In the meantime, magnetometers are used in many environments and for many purposes including, security, defense, detection, environmental monitoring and the like.

Our analysis of this patent is as follows:

Broadband Discovery Systems, Inc.’s patent US 9354291 B2 deals with Dynamically self-adjusting magnetometer.
A dynamically self-adjusting magnetometer revealed. In one image, a first sample module each generate an electronic signal associated with at least one magnetic field characteristics of a monitor environment. A second sample module each generate an electronic signal associated with at least one magnetic field characteristics of a monitor environment. A computing module summarizes the full value of the electronic signal from the first sample module and the electronic signal from the second sample module. A delta comparator module receives electronic signals from each of the first sample module, the second sample module and the computing module and compares each of the electronic signal to a previously received set of electronic signals to build a change, which is an output generated when the change is greater than or equal to a threshold.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Biosensor using whispering gallery modes in microspheres

Protect your invention by filing a Provisional or Utility Patent Application using our software today! It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Genera Biosystems Limited patent solves the following problem:

The present invention relates generally to the field of analyte detection. Particularly, the present invention relates to the use of changes in the Whispering Gallery Mode (WGM) profile microspheroidal particles prompting the analyte sealing a move valued partner of the particles as observed in the presence of analyte. The present invention further relates to multiplexing protocol and detection of analytes in profile changes WGM.

Our analysis of this patent is as follows:

Genera Biosystems Limited’s patent US 9354174 B2 deals with Biosensor using whispering gallery modes in microspheres.
A biosensor to identify the presence of a target analyte is exposed. biosensor formed from the microspheroidal particles with a binding partner for the target analyte act on their surfaces. The binding partners may nucleotides; peptides, proteins, enzymes, antibodies and the like. When the analyte binds to its partner, the whispering gallery mode (WGM) profile of the micro spheroidal particles in the same top profile through a deep blue-shift. The move cost partners may include fluorophores and the like so that they emit fluorescence, phosphorescence, incandescence and the like. These fluorophores to take the form of a nanocrystal or quantum dots.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Detecting stannous ions

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time for Utility, Provisional or Design Patent Creation with PowerPatent software and services.

The Colgate-Palmolive Company patent solves the following problem:

Stannous ion (Sn2 +) is used in oral care compositions because they show biocidal activity and effective in preventing dental erosion (Rakhmatullina et al, 2013. When the enamel erosion stannous and fluoride containing rinsing solution , Schweiz Monatsschr Zahnmed, vol. 123, pp. 192-197). Aqueous solution containing stannous ion reported unstable (Nevitt et al, 1958. Topical application of sodium fluoride and stannous fluoride, Public Health Rep, vol. 73, no 9, pp. 847-850). Strength is an important property to consider when making an oral care composition. Therefore a need for a way to test oral composition to care for the presence of stannous ion.

Our analysis of this patent is as follows:

Colgate-Palmolive Company’s patent US 9354219 B1 deals with Detecting stannous ions.
A method of detecting stannous ion that includes providing a zincon a sign with a color, contact signs on a sample, and identify any resulting change in color of signs, where a change the color of the indicator color from colorless showed that stannous ion in the sample. method is useful for analysis in oral care compositions. Also provides the use of zinc as a sign of recognition stannous ion.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Apparatus and system for imaging currency bills and financial documents and method for using the same

Protect your invention by filing a Provisional or Utility Patent Application using our software today! It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Cummins-Allison Corp. patent solves the following problem:

Previous document processing devices for financial documents with various disabilities.

Our analysis of this patent is as follows:

Cummins-Allison Corp.’s patent US 9355295 B1 deals with Apparatus and system for imaging currency bills and financial documents and method for using the same.
The device has a deposit, a sell, and an audit by the operation of the monitor and reconcile bills. The device includes a memory for storing records, an input box to receive the bills, an image scanner bills, a transport mechanism to bring bills, and the one or more processors. The deposit method, the one or more processors took serial numbers and creating records. Each record includes a physical farm bill location showing the location of the bill is expected to be physically located. Sold by one or more processors update the physical field where the bill showed that the expected physical bill was a second place. The audit process, one or more processors to determine if each record corresponds with an audit record and creating a sign that the teller drawer is responsive to a determination that each audit record as with an individual record and a determination that each record equivalent to an audit record.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Methods of treating pain using an antibody specific for GM-CSF

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with a PowerPatent Utility, Provisional or Design Patent Application

The The University Of Melbourne patent solves the following problem:

pain

Our analysis of this patent is as follows:

The University Of Melbourne’s patent US 9352034 B2 deals with Methods of treating pain using an antibody specific for GM-CSF.
The present invention relates generally to a method for the treatment and Branch Tomato pain. According to the present invention, it is suggested that antagonists of GM-CSF effective in the treatment of pain. Antagonists of GM-CSF include, but are not limited to, the antibody specific for GM-CSF or GM-CSF receptor. The present invention further provides transgenic animals, such as a GM-CSF knock-out mouse, useful for testing antagonists in several disease models.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Very dense nonvolatile memory bitcell

File for Quick & Easy Patent Protection with PowerPatent.

The Synopsys, Inc. patent solves the following problem:

Disclosure This generally relates to the field of nonvolatile memories, especially non volatile memory bitcell layouts.

Our analysis of this patent is as follows:

Synopsys, Inc.’s patent US 9355728 B2 deals with Very dense nonvolatile memory bitcell.
An asymmetric non-volatile memory bitcell described. bitcell contains the source and drain regions containing carrier in the same manner conductivity. A floating gate is over the well, and gave a channel region, and at least a portion of the source and drain regions. The drain region contains more carriers of a second type conductivity, allowing the band to band tunneling. The source region contains more carriers of a first type conductivity, thus increasing the gate source capacitance. Therefore, the bitcell contain a selected device, thus reducing the overall size of bitcell. bitcell be done without any additional process steps CMO, or by the addition of a further step mask.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

System and method for detecting rated maximum system deviation (RMSD) and alleviating RMSD mismatch

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with a PowerPatent Utility, Provisional or Design Patent Application

The Marvell International Ltd. patent solves the following problem:

Receivers detect stereophonic / monophonic signal can be incorporated into a wide range of devices used in daily life. For example, the radio receiver used in vehicles, a variety of communication systems such as cellular telephones, and even children's toys. Sadly, many modern receiver systems may suffer from the lack of performance, as always switchover between monophonic and stereophonic way around for sound channel and false detection stereophonic signal as monophonic because the rated maximum system deviation (RMSD) mismatch.

Our analysis of this patent is as follows:

Marvell International Ltd.’s patent US 9356638 B1 deals with System and method for detecting rated maximum system deviation (RMSD) and alleviating RMSD mismatch.
An FM audio receiver can include a mono / stereo detector that caused the audio receiver to output either a monophonic or a stereophonic signal based on a received pilot tone energy. A proper operation of receivers, including, but not limited to straighten out the meaning of the monophonic / stereophonic receiving a base receiver operate at the same rated maximum system deviation (RMSD) as the received signal itself. Aspects of the disclosure described a system and method for detecting and matching RMSD a recipient of a received signal by demodulating a carrier bearing one of an input signal on a first bandwidth, getting a pilot energy signal from the input signal, and demodulating the carrier having the input signal on a second bandwidth if the pilot signal energy is in a pilot energy range for a first predetermined amount of time.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Use of PKC-iota inhibitors for the treatment of breast cancer

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time for Utility, Provisional or Design Patent Creation with PowerPatent software and services.

The University Of South Florida, , The United States Of America As Represented By The Department Of Veterans Affairs patent solves the following problem:

Breast cancer is the most common female cancer and the leading cause of cancer related death among women. The 2009 cancer statistics estimated that 181,000 new cases of invasive breast cancer were diagnosed that year and resulting in 46,300 new deaths. In North America, breast cancer accounts for about 27% of all female cancers and 15% -20% of all female cancer mortalities. While progress in the diagnosis and treatment of breast cancer and prolong patient survival, alternative therapeutic agents for the treatment of breast cancer is needed.

Our analysis of this patent is as follows:

University Of South Florida, , The United States Of America As Represented By The Department Of Veterans Affairs’s patent US 9351981 B2 deals with Use of PKC-iota inhibitors for the treatment of breast cancer.
The subject invention relates to the use of PKC-iota inhibitor for the treatment of breast cancer. In one embodiment, the subject invention provides novel 1H-imidazole-4-carboxamide, 5-amino-1- [2,3-dihydroxy-4 – [(phosphonooxy) methyl] cyclopentyl], [1R- (1, 2, 3, 4)] (ICA-1) and related compounds for the treatment of breast cancer. The compounds of the subject invention have potent anti-proliferative effects against human breast cancer cells. The compounds of the subject invention also inhibit the phosphorylation of IKK- / IKK-, induce chromatin condensation, and / or induce DNA fragmentation in cancer cells.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Calicheamicin derivative-carrier conjugates

Use PowerPatent’s Online Patent Filing Service to get quick patent protection for your great idea.

The Wyeth Holdings Llc patent solves the following problem:

Drug conjugates developed for systemic pharmacotherapy target-specific cytotoxic agents. concept involves coupling a therapeutic agent to a carrier molecule with specificity for a defined target cell population. Antibody with high affinity for antigens is a natural choice as targeting moieties. With the availability of high affinity monoclonal antibody, the prospects of antibody-targeting therapeutics were promised. Toxic substances that are conjugated monoclonal antibody include toxins, low-molecular-weight cytotoxic drugs, biological response modifiers, and radionuclides. Antibody-toxin conjugates commonly known as immunotoxins, whereas immunoconjugates consisting of antibodies and low-molecular-weight drugs like methothrexate and adriamycin called chemoimmunoconjugates. Immunomodulators include biological response modifiers known to have regulatory functions such as lymphokines, growth factors, and complement-activating cobra venom factor (CVF). Radioimmunoconjugates containing radioactive isotopes, which can be used as therapeutics to kill cells in their radiation or used for imaging. Antibody-mediated specific delivery of cytotoxic drugs to the tumor cells is expected not only to increase their anti-tumor efficacy, but also to prevent nontargeted uptake in normal tissues, thus increasing their therapeutic lab -a.

Our analysis of this patent is as follows:

Wyeth Holdings Llc’s patent US 9351986 B2 deals with Calicheamicin derivative-carrier conjugates.
Methods of preparing monomeric cytotoxic drug / carrier conjugates with a drug loading significantly higher than previously reported procedures and with decreased aggregation and low conjugate fraction (LCF) described. Cytotoxic drug derivative / antibody conjugates, compositions comprising the conjugates and uses of the conjugates are also described. Monomeric calicheamicin derivative / anti-CD22 antibody conjugates, compositions comprising the conjugates and uses of the conjugates are also described.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Substituted purine nucleosides, phosphoroamidate and phosphorodiamidate derivatives for treatment of viral infections

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time for Utility, Provisional or Design Patent Creation with PowerPatent software and services.

The Inhibitex, Inc., , University College Cardiff Consultants Limited patent solves the following problem:

HCV is a member of the Flaviviridae family of RNA viruses that affect animals and humans. genome is a 9.6-kilobase strand of RNA, and consists of an open reading frame that encodes for a polyproteins of approximately 3000 amino acids flanked by untranslated regions at both 5 and 3 point (5- and 3-UTR). polyproteins served as the precursor to at least 10 separate viral proteins critical for replication and assembly of the viral particles.

Our analysis of this patent is as follows:

Inhibitex, Inc., , University College Cardiff Consultants Limited’s patent US 9351989 B2 deals with Substituted purine nucleosides, phosphoroamidate and phosphorodiamidate derivatives for treatment of viral infections.
It aims to creation phosphoroamidate and phosphorodiamidate derivatives including the compounds of formula (I) with a building which U, V, W, Z, R1, X1, X2, and I described here. These compounds and pharmaceutical compositions containing these compounds useful in the treatment of viral infections in mammals infected with a virus in the Flaviviridae family of viruses, in particular hepatitis C virus (HCV). The compounds of the invention can be prepared in various ways known in the art of organic chemistry in general and nucleoside and nucleotide analog synthesis in particular.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.